Diclofenac etalhyaluronate | Interleukin Related interleukin-related.com

Product Name :
Diclofenac etalhyaluronate

Search keywords :
Diclofenac

drugId :
null

Target Vo:
Cyclooxygenases

Target Vo Short Name :
COXs

Moa_Name:
Cyclooxygenases inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2021

Origin Company_Name :
Seikagaku

Active Company_Name :
Ono Pharmaceutical Co Ltd

Active Indication_Name:
Osteoarthritis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NEDD8 Antibody
SOD2 Antibody (YA670)
PDX1 Antibody: PDX1 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 31 kDa, targeting to PDX1. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts